Table 1.

Clinical Data

PatientGenderAge at Onset of KDIVIG TherapyDays of Illness When IVIG GivenCABGAge at TransplantTime of Transplant After KDAge at
Follow-up
1M14 yYes11No14 y11 weeks19 y
2M 3 moYes7 and 10No 6 mo  3 mo 3 y
3M 3 yYes9Yes 3 y 7 days 4 y
4M 6 yNoneN/AYes 8 y 2 y10 y
5M 2 yNoneN/ANo13 y11 y17 y
6F 4 yYes9 and 11No 4 y 6 mo 5 y*
7M 8 yNoneN/ANo13 y 5 y19 y
8F 4 moYes13No19 m15 mo 4 y
9F 5 yNoneN/AYes14 y 9 y18 y
10M13 moNoneN/AYes13 y12 y18 y
  • * Patient death at 5 years of age.

  • Patient required retransplantation at 16 years of age for severe rejection.

    KD indicates Kawasaki disease; IVIG, intravenous immune globulin; CABG, coronary artery bypass graft.